tbuckley/cabot-search huggingface dataset:
Prognostic Significance of NCAM1 (CD56) Expression in AML Patients Treated with HMA+Venetoclax
Authors: Jennifer N. Saultz, Manoj Rai, Faith Burns, Daniel J Chandra, Sunil K Joshi, Curtis A. Lachowiez, Andy Kaempf, Andrew N Nemecek, Yoko Kosaka, Evan F. Lind, Stephen E. Kurtz, Nicola Long, Rachel Cook, Gabrielle Meyers, Arpita Gandhi, Jessica T. Leonard, Brandon Hayes-Lattin, Laura F. Newell, Richard T Maziarz, Elie Traer, Ronan T. Swords, Theodore P Braun, Cristina Tognon, Jeffrey W Tyner
Journal: Blood (2023)
Efficacy of Chemo-Free Combination Therapy with BRAF Inhibitor and Rituximab in Classic Hairy Cell Leukemia: Insights from the French Experience
Authors: Luca Inchiappa, Lise Willems, Jérôme Paillassa, Charles Herbaux, Cecile Tomowiak, Anne Lok, Diane Lara, Bijou Fontanet, Urbain Tauveron-Jalenques, Antoine Ittel, Adrien Caillet, Norbert Vey, Xavier Troussard
Journal: Blood (2023)
Health Care Resource Utilization (HCRU) and Cost of Management of Cytokine Release Syndrome (CRS) and Neurological Events (NEs) in Patients with R/R Follicular Lymphoma (FL) Receiving Lisocabtagene Maraleucel (liso-cel) in the TRANSCEND FL Study
Authors: Ashley C. Saunders, Tavneet Singh, Abraham Lee, Thalia Farazi, Omotayo Fasan, Sana Mirza, November McGarvey
Journal: Blood (2023)
Hnrnpk Overexpression Drives Nucleolar Aberrancies Causing Ribosomopathies
Authors: Pedro Aguilar-Garrido, Maria Velasco-Estevez, Miguel Ángel Navarro-Aguadero, María Hernández-Sánchez, Marta Ibáñez-Navarro, Prerna Malaney, Marisa Aitken, Xiaorui Zhang, Adrián Fernández, Alejandra Ortiz-Ruiz, Álvaro Otero-Sobrino, Diego Megías, Manuel Pérez, Jesús Gómez, Gadea Mata, Orlando Domínguez, Osvaldo Graña, Pilar Ximénez, Marta Isasa, Paloma Jimena-de Andrés, Sandra Rodríguez, Raúl Torres, Miguel Lafarga, Oleksandra Sirozh, Vanesa Lafarga, Joaquin Martinez-Lopez, Sean M. Post, Miguel Gallardo
Journal: Blood (2023)
Ten years of injectable platelet‐rich fibrin
Authors: Richard J. Miron, Reinhard Gruber, Nima Farshidfar, Anton Sculean, Yufeng Zhang
Journal: Periodontology 2000 (2023)

Abstract The use of platelet‐rich fibrin (PRF) has seen widespread advantages over platelet‐rich plasma (PRP) in many fields of medicine. However, until 2014, PRF remained clinically available only in its solid clotted form. Modifications to centrifugation protocols and tube technology have led to the development of a liquid injectable version of PRF (i‐PRF). This narrative review takes a look back at the technological developments made throughout the past decade and further elaborates on their future clinical applications. Topics covered include improvements in isolation techniques and protocols, ways to further concentrate i‐PRF, and the clinical impact and relevance of cooling i‐PRF. Next, various uses of i‐PRF are discussed, including its use in regenerative periodontology, implantology, endodontics, temporomandibular joint injections, and orthodontic tooth movement. Furthermore, various indications in medicine are also covered, including its use in sports injuries and osteoarthritis of various joints, treatment of diabetic ulcers/wound care, and facial esthetics and hair regrowth. Finally, future applications are discussed, mainly its use as a drug delivery vehicle for small biomolecules, such as growth factors, antibiotics, exosomes, and other medications that may benefit from the controlled and gradual release of biomolecules over time.
Empowering Global Hematology-Oncology Education: Assessing the Impact of a 1.5-Year Virtual Platform in Combating Miseducation &amp; Inequity
Authors: Yan Leyfman, Alexandra Van de Kieft, Muskan Joshi, Gayathri P. Menon, Maduri Balasubramanian, Elizabeth J. Heller, Keira P. Smith, Ahmed Hashim, Helena S. Coloma, Gabriele Alves, William B. Wilkerson, Chandler Howard Park
Journal: Blood (2023)
Acute Abdominal and Pelvic Complications in Patients with Non-Promyelocytic Acute Myeloid Leukaemia Undergoing Intensive Induction Chemotherapy Are Associated with Favorable Prognosis
Authors: Philip T Murphy, Mohammed Alsaleh, Harris Cheema, Quinn John, Siobhan Glavey, Jeremy Sargent, Dawn Jennifer Swan
Journal: Blood (2023)
Key Prognostic Factors in Patients with Relapsed/Refractory Follicular Lymphoma: An Evidence Based Systematic Literature and Medical Review
Authors: Ana Jimenez Ubieto, Pau Abrisqueta Costa, Christian Hampp, Shivani Aggarwal, Mohsin Shah, Laura Walsh, Eileen Thorley, Qiufei Ma, Bastian von Tresckow
Journal: Blood (2023)
A D-Dimer and Thrombin Generation-Based Risk Score Predicts Early-Disease Recurrence in a Prospective Cohort of 1,059 High-Risk Breast Cancer Patients
Authors: Patricia Gomez-Rosas, Marina Marchetti, Cinzia Giaccherini, Laura Russo, Cristina Verzeroli, Sara Gamba, Carmen Julia Tartari, Silvia Bolognini, Chiara Ticozzi, Francesca Schieppati, Luca Barcella, Roberta Sarmiento, Giovanna Masci, Carlo Tondini, Fausto Petrelli, Francesco Giuliani, Andrea D'Alessio, Filippo De Braud, Armando Santoro, Roberto Labianca, Giampietro Gasparini, Anna Falanga
Journal: Blood (2023)
Outcomes of Patients Receiving Intensive Therapy for Acute Myeloid Leukemia Relapsed after/Refractory to Frontline Less-Intensive Therapy
Authors: Rohan Achar, Benjamin J. McCormick, Emily Dworkin, Emily Geramita, Annie Im, Anand Ashwin Patel, Talha Badar, Rory M. Shallis
Journal: Blood (2023)
TKI Dose Optimization Based on Therapeutic Drug Monitoring（TDM) with Encouraging Outcomes and Well-Tolerated for Chronic Myeloid Leukaemia Patients
Authors: Zherou He, Xuan Zhou, Ziyu Wen, Zicheng Gao, Hong Chen, Qiang Wang, Hanyin Liang, Dongmei Luo, Xiaoli Liu, Na Xu, Qifa Liu
Journal: Blood (2023)
Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric Cancer
Authors: Ru-Hong Tu, Sheng-Ze Wu, Ze-Ning Huang, Qing Zhong, Yin-Hua Ye, Chao-Hui Zheng, Jian-Wei Xie, Jia-Bin Wang, Jian-Xian Lin, Qi-Yue Chen, Chang-Ming Huang, Mi Lin, Jun Lu, Long-Long Cao, Ping Li
Journal: Cancer Research (2023)

Abstract Nerves can support tumor development by secreting neurotransmitters that promote cancer cell proliferation and invasion. 5-Hydroxytryptamine (5-HT) is a critical neurotransmitter in the gastrointestinal nervous system, and 5-HT signaling has been shown to play a role in tumorigenesis. Here, we found that expression of the 5-HT receptor HTR2B was significantly elevated in human gastric adenocarcinoma tissues compared with nontumor tissues, and high HTR2B expression corresponded to shorter patient survival. Both 5-HT and a specific HTR2B agonist enhanced gastric adenocarcinoma cell viability under metabolic stress, reduced cellular and lipid reactive oxygen species, and suppressed ferroptosis; conversely, HTR2B loss or inhibition with a selective HTR2B antagonist yielded the inverse tumor suppressive effects. In a patient-derived xenograft tumor model, HTR2B-positive tumors displayed accelerated growth, which was inhibited by HTR2B antagonists. Single-cell analysis of human gastric adenocarcinoma tissues revealed enrichment of PI3K/Akt/mTOR and fatty acid metabolism–related gene clusters in cells expressing HTR2B compared with HTR2B-negative cells. Mechanistically, HTR2B cooperated with Fyn to directly regulate p85 activity and trigger the PI3K/Akt/mTOR signaling pathway, which led to increased expression of HIF1α and ABCD1 along with decreased levels of lipid peroxidation and ferroptosis. Together, these findings demonstrate that HTR2B activity modulates PI3K/Akt/mTOR signaling to stimulate gastric cancer cell survival and indicate that HTR2B expression could be a potential prognostic biomarker in patients with gastric cancer. Significance: Nerve cancer cross-talk mediated by HTR2B inhibits lipid peroxidation and ferroptosis in gastric cancer cells and promotes viability under metabolic stress, resulting in increased tumor growth and decreased patient survival.
Melanoma risk in skin of color patients with a history of a keratinocyte carcinoma
Authors: Cassandra Mohr, Yao Li, Lucy J Navsaria, Candice L Hinkston, David J Margolis, Mackenzie R Wehner
Journal: British Journal of Dermatology (2023)

This manuscript uses individual-level data from 5 million Medicare beneficiaries to investigate the risks of melanoma in skin of color patients with a history of keratinocyte carcinoma. Despite worse melanoma outcomes, skin of color patients are often excluded from skin cancer literature. We found that skin of color patients with a history of keratinocyte carcinoma are at a significantly increased risk of melanoma, though their absolute risk is low.
Perceptions of Data Set Experts on Important Characteristics of Health Data Sets Ready for Machine Learning
Authors: Madelena Y. Ng, Alaa Youssef, Adam S. Miner, Daniela Sarellano, Jin Long, David B. Larson, Tina Hernandez-Boussard, Curtis P. Langlotz
Journal: JAMA Network Open (2023)

Importance The lack of data quality frameworks to guide the development of artificial intelligence (AI)-ready data sets limits their usefulness for machine learning (ML) research in health care and hinders the diagnostic excellence of developed clinical AI applications for patient care. Objective To discern what constitutes high-quality and useful data sets for health and biomedical ML research purposes according to subject matter experts. Design, Setting, and Participants This qualitative study interviewed data set experts, particularly those who are creators and ML researchers. Semistructured interviews were conducted in English and remotely through a secure video conferencing platform between August 23, 2022, and January 5, 2023. A total of 93 experts were invited to participate. Twenty experts were enrolled and interviewed. Using purposive sampling, experts were affiliated with a diverse representation of 16 health data sets/databases across organizational sectors. Content analysis was used to evaluate survey information and thematic analysis was used to analyze interview data. Main Outcomes and Measures Data set experts’ perceptions on what makes data sets AI ready. Results Participants included 20 data set experts (11 [55%] men; mean [SD] age, 42 [11] years), of whom all were health data set creators, and 18 of the 20 were also ML researchers. Themes (3 main and 11 subthemes) were identified and integrated into an AI-readiness framework to show their association within the health data ecosystem. Participants partially determined the AI readiness of data sets using priority appraisal elements of accuracy, completeness, consistency, and fitness. Ethical acquisition and societal impact emerged as appraisal considerations in that participant samples have not been described to date in prior data quality frameworks. Factors that drive creation of high-quality health data sets and mitigate risks associated with data reuse in ML research were also relevant to AI readiness. The state of data availability, data quality standards, documentation, team science, and incentivization were associated with elements of AI readiness and the overall perception of data set usefulness. Conclusions and Relevance In this qualitative study of data set experts, participants contributed to the development of a grounded framework for AI data set quality. Data set AI readiness required the concerted appraisal of many elements and the balancing of transparency and ethical reflection against pragmatic constraints. The movement toward more reliable, relevant, and ethical AI and ML applications for patient care will inevitably require strategic updates to data set creation practices.
Correspondence to ‘association between chronic rhinosinusitis and new onset asthma implications for prevention’
Authors: Iressa Cheng, Chin‐Yuan Yii, Liang‐Chun Shih, Jiu Yao Wang, Su‐Boon Yong
Journal: Allergy (2023)

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Global prevalence of cardiovascular risk factors based on the Life's Essential 8 score: an overview of systematic reviews and meta-analysis
Authors: Rubén López-Bueno, Rodrigo Núñez-Cortés, Joaquín Calatayud, Joaquín Salazar-Méndez, Fanny Petermann-Rocha, José Francisco López-Gil, Borja del Pozo Cruz
Journal: Cardiovascular Research (2023)

Abstract Cardiovascular health (CVH) is a critical issue for global health. However, no previous study has determined the prevalence of cardiovascular risk factors based on the American Heart Association’s (AHA) Life’s Essential 8 (LE8). Therefore, we aimed to estimate the global prevalence of the eight cardiovascular risk factors identified in the LE8. A systematic search of systematic reviews with meta-analysis on cardiovascular risk factors covering data reported between 2000 and 2019 was conducted on PubMed, Epistemonikos, and the Cochrane Library until 1 May 2023. After applying exclusion criteria, 79 studies remained in the final selection for the narrative synthesis in the systematic review, of which 33 of them were used in the meta-analysis which included 2 555 639 participants from 104 countries. The overall pooled prevalence of cardiovascular risk factors was as follows: insufficient physical activity, 26.3% (95% CI 2.3%–63.4%), no adherence to a healthy diet, 34.1% (95% CI 5.8%–71.2%), nicotine exposure, 15.4% (95% CI 10.4%–21.2%), insufficient sleep quality, 38.5% (95% CI 14.0%–66.7%), obesity, 17.3% (95% CI 6.1%–32.6%), dyslipidemia, 34.1% (95% CI 33.8%–34.4%), diabetes, 12.0% (95% CI 7.0%–18.2%), and hypertension, 29.4% (95% CI 23.3%–35.8%). These results warrant prevention strategies aimed at reducing insufficient sleep quality, and no adherence to a healthy diet as leading cardiovascular risk factors worldwide. The high prevalence of hypertension among children and adults is concerning and should also be adequately addressed through global policies.
Prone Positioning During Venovenous ECMO for Severe ARDS
Authors: Ricardo Teijeiro-Paradis, Niall D. Ferguson
Journal: JAMA (2023)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS
Authors: Matthieu Schmidt, David Hajage, Guillaume Lebreton, Martin Dres, Christophe Guervilly, Jean Christophe Richard, Romain Sonneville, Hadrien Winiszewski, Gregoire Muller, Gaëtan Beduneau, Emmanuelle Mercier, Hadrien Roze, Mathieu Lesouhaitier, Nicolas Terzi, Arnaud W. Thille, Isaura Laurent, Antoine Kimmoun, Alain Combes, Charles Edouard Luyt, Guillaume Hekimian, Nicolas Brechot, Juliette Chommeloux, Marc Pineton de Chambrun, Ouriel Saura, David Levy, Lucie Lefevre, Benjamin Assouline, Petra Bahroum, Melchior Gautier, Pascal Leprince, Charles Juvin, Pierre Demondion, Elodie Bergue, Pichoy Danial, Hamed Al-kabani, Karl Bounader, Thibaut Schoell, Cosimo D'Allesandro, Côme Bureau, Julien Le Marec, Julien Mayaux, Maxens Decavèle, Alexandre Demoule, Robin Deleris, Safaa Nemlaghi, Marie Lecronier, Gilles Capellier, Gael Piton, Francois Belon, Thibault Vieille, Valentin Lafay, Camille Manfait, Romain Tapponnier, Nicolas Belin, Arnaud Gacouin, Jean-Marc Tadié, Laurent Papazian, Sami Hraiech, Jean-Marie Forel, Antoine Roch, Mélanie Adda, Florence Daviet, Ines Gragueb-Chatti, Laura Textoris, Jean-François Timsit, Lila Bouadma, Etienne de Montmollin, Fariza Lamara, Véronique Deiler, Marylou Para, Patrick Nataf, Sylia Zmihi, Paul Henri Wicky, Juliette Patrier, Pierre Jaquet, Bruno Levy, Pierre Perez, Carine Thivilier, Mathieu Mattei, Clément Haddadi, Matthieu Kozutski, Pablo Maureira, Hodane Yonis, Medhi Mezidi, Louis Chauvelot, William Danjou, Francois Dhelft, Laurent Bitker, Clotilde Bettinger, Pauline Bernon, Grégoire Jolly, Dorothée Carpentier, Mai-Anh Nay, Thierry Boulain, Toukif Kamel, Francois Barbier, Anne Bretagnol, Armelle Mathonnet, Maxime Desgrouas, Marie Skarzynski, Benjamin Repusseau, Florian Sigaud, Guillaume Rigault, Louis-Marie Galerneau, Carole Schwebel, Clara Candille, Anaïs Dartevel, Joanna Bougnaud, Emanuele Turbil, Stephan Ehrmann, Denis Garot, Charlotte Salmon, Sylvain Le Pape, Francois Arrivé
Journal: JAMA (2023)

Prone positioning may improve outcomes in patients with severe acute respiratory distress syndrome (ARDS), but it is unknown whether prone positioning improves clinical outcomes among patients with ARDS who are undergoing venovenous extracorporeal membrane oxygenation (VV-ECMO) compared with supine positioning.
Corrigendum to: Towards more Diversity in Neuro-oncology Leadership—the DivINe Initiative
Journal: Neuro-Oncology (2023)

Additional criteria apply.Please refer to protocol 14379-201 for full inclusion and exclusion criteria.† Patients can participate if they had some skin cancers, superficial bladder cancer (cancer that was only on the surface of the lining of the bladder), or carcinoma in situ (cancer that had not spread) of the cervix or breast that had been cured.HIV, human immunodeficiency virus; HBV, hepatitis B virus; HCV, hepatitis C virus; IGF-1R, insulin-like growth factor 1 receptor; KPS, Karnofsky Performance Scale; RT, radiotherapy; SOC, standard of care; TMZ, temozolomide.
Mobilizable plasmids drive the spread of antimicrobial resistance genes and virulence genes in Klebsiella pneumoniae
Authors: Jianfeng Zhang, Yanping Xu, Meng Wang, Xiaobin Li, Zhiyuan Liu, Dai Kuang, Zixin Deng, Hong-Yu Ou, Jieming Qu
Journal: Genome Medicine (2023)

Abstract Background Klebsiella pneumoniae is a notorious clinical pathogen and frequently carries various plasmids, which are the main carriers of antimicrobial resistance and virulence genes. In comparison to self-transmissible conjugative plasmids, mobilizable plasmids have received much less attention due to their defects in conjugative elements. However, the contribution of mobilizable plasmids to the horizontal transfer of antimicrobial resistance genes and virulence genes of K. pneumoniae remains unclear. In this study, the transfer, stability, and cargo genes of the mobilizable plasmids of K. pneumoniae were examined via genetic experiments and genomic analysis . Methods Carbapenem-resistant (CR) plasmid pHSKP2 and multidrug-resistant (MDR) plasmid pHSKP3 of K. pneumoniae HS11286, virulence plasmid pRJF293 of K. pneumoniae RJF293 were employed in conjugation assays to assess the transfer ability of mobilizable plasmids. Mimic mobilizable plasmids and genetically modified plasmids were constructed to confirm the cotransfer models. The plasmid morphology was evaluated through Xba I and S1 nuclease pulsed-field gel electrophoresis and/or complete genome sequencing. Mobilizable plasmid stability in transconjugants was analyzed via serial passage culture. In addition, in silico genome analysis of 3923 plasmids of 1194 completely sequenced K. pneumoniae was performed to investigate the distribution of the conjugative elements, the cargo genes, and the targets of the CRISPR-Cas system. The mobilizable MDR plasmid and virulence plasmid of K. pneumoniae were investigated, which carry oriT but lack other conjugative elements. Results Our results showed that mobilizable MDR and virulence plasmids carrying oriT but lacking the relaxase gene were able to cotransfer with a helper conjugative CR plasmid across various Klebsiella and Escherichia coli strains. The transfer and stability of mobilizable plasmids rather than conjugative plasmids were not interfered with by the CRISPR–Cas system of recipient strains. According to the in silico analysis, the mobilizable plasmids carry about twenty percent of acquired antimicrobial resistance genes and more than seventy-five percent of virulence genes in K. pneumoniae. Conclusions Our work observed that a mobilizable MDR or virulence plasmid that carries oriT but lacks the relaxase genes transferred with the helper CR conjugative plasmid and mobilizable plasmids escaped from CRISPR–Cas defence and remained stable in recipients. These results highlight the threats of mobilizable plasmids as vital vehicles in the dissemination of antibiotic resistance and virulence genes in K. pneumoniae .
Chemotherapy-Sparing Induction Followed By Consolidation and Maintenance with Blinatumomab and Concurrent Oral Tyrosine Kinase Inhibitor Therapy for Newly-Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Primary Endpoint Results from the Blissphall Study
Authors: Mark Blaine Geyer, John Mascarenhas, Marissa Smith, Shakira Pascual, Anmol Shah, Michael R. Silvestrone, Tina Czaplinska, Kathryn Johnson, Meghan C. Thompson, Jae H. Park
Journal: Blood (2023)
<i>Aberrant Expression of Spliced WNK2 Is an Early Event in MYD88 Mutated WM That Activates ERK1/2 and Supports Tumor Growth</i>
Authors: Maria Luisa Guerrera, Zachary R Hunter, Kris Richardson, Nickolas Tsakmaklis, Amanda Kofides, Shirong Liu, Christopher J Patterson, Eugenio Morelli, Jorge J. Castillo, Shayna R Sarosiek, Catherine A. Flynn, Kirsten Meid, Andrew R. Branagan, Ruben D. Carrasco, Kenneth C. Anderson, Nikhil C Munshi, Steven P Treon, Xia Liu
Journal: Blood (2023)
Adaptive Manufacturing of LV20.19 CAR T-Cells for Relapsed, Refractory Mantle Cell Lymphoma
Authors: Nirav N. Shah, Fateeha Furqan, Aniko Szabo, Tyce Kearl, Anthony Zamora, Jessica Neumann, Parameswaran N. Hari, Dina Schneider, Walter Longo, Peiman Hematti, Bryon D. Johnson, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood (2023)
High Neoantigen Load Confers a Major Benefit from Autologous Stem Cell Transplantation Compared to Consolidation in Newly Diagnosed Multiple Myeloma
Authors: Ieuan Walker, Venetia D'Arcy, Kane Foster, Garima Khandelwal, Georgina S.F. Anderson, William Wilson, Evie Fitzsimons, Daria Galas-Filipowicz, Rakesh Popat, Karthik Ramasamy, Matthew Streetly, Ceri Bygrave, Reuben Benjamin, Ruth M de Tute, Marquita Camilleri, Selina J Chavda, Gavin Pang, Sumaiya Kamora, James D. Cavenagh, Elizabeth Phillips, Laura Clifton-Hadley, Charlotte Tyson, Fuad Fananapazir, Krupali Parikh, Roger Owen, Javier Herrero, Kwee Yong, Michael A. Chapman
Journal: Blood (2023)
Infection Outcomes and Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Treated with Immunoglobulin Replacement Therapy
Authors: Jacob Soumerai, Thais Gift, Zaid Yousif, Raj Desai, Lynn Huynh, Gregory Belsky, Mei Sheng Duh, Marie Sanchirico
Journal: Blood (2023)
Venetoclax Resistance Results in Broad Resistance to Majority of Anti-MM Agents Due to the Suppression of Apoptosis but Can be Overcome By BCMA-Targeted Immunotherapy
Authors: Mariateresa Fulciniti, Shuhui Deng, Sanika Dereibal, Vera Joy Weiler, Madhumouli Chatterjee, Jessica Ng Fong, Chandraditya Chakraborty, Rao Prabhala, Masood A. Shammas, Anil Aktas-Samur, Mehmet K. Samur, Annamaria Gulla, Kenneth C. Anderson, Nikhil C Munshi
Journal: Blood (2023)
Efficacy of Bispecific Antibodies Vs CAR-T in the Treatment of Extramedullary Disease and High-Risk Cytogenetics in Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis
Authors: Charan Thej Reddy Vegivinti, Jaison Lawrence Alexander Santhi, Lawrence Liu, Praneeth Reddy Keesari, Rahul Thakur, M Bakri Hammami, Venkatesh Kapu, Sindhu Pericherla, Murali Mohan reddy Gopireddy, Nagarathna Poojary, Ananta Ghimire, Nishi Shah, Murali Janakiram
Journal: Blood (2023)